Results 211 to 220 of about 132,229 (258)

Neoadjuvant Chemotherapy for Nonmetastatic Osteosarcoma of the Extremities

Clinical Orthopaedics and Related Research, 1991
Between September 1986 and December 1988, 125 patients with osteosarcoma of the extremities entered the second neoadjuvant study at the authors' institution. Patients received preoperatively two cycles of methotrexate (MTX) intravenously, followed by cisplatinum (CDP) intraarterially, plus adriamycin (ADM) intravenously.
BACCI G, PICCI P, PIGNATTI G, DECRISTOFARO R, DALLARI D, AVELLA M, MANFRINI M, MARANGOLO M, FERRUZZI A, MERCURI M, RUGGIERI P, BIAGINI R, CAPANNA, RODOLFO, FERRARI S, PRASAD R, CAMPANACCI M.   +15 more
openaire   +4 more sources

NEOADJUVANT CHEMOTHERAPY IN GYNECOLOGIC ONCOLOGY

Surgical Clinics of North America, 2001
The use of neoadjuvant chemotherapy in conjunction with surgery in squamous carcinoma of the uterine cervix can reduce the surgical treatment extent (to be confirmed) in small-volume tumors (diameter < 4 cm) and increase overall survival and disease-free interval in localized median-volume tumors (< or = 8 cm) and improve the quality of life of ...
openaire   +2 more sources

Neoadjuvant chemotherapy in cervix cancer

1994
Despite the decrease in the incidence of cervix cancer over the last decade, 13 500 new cases and 4400 deaths were expected in the United States in 1992 [1]. Accessibility of the cervix for cytologic evaluation via the Pap smear, visual inspection by colposcopy, and histologic evaluation by biopsy have made cervical cacer a preventable and potentially ...
P R, Dottino, R A, Segna
openaire   +2 more sources

Neoadjuvant chemotherapy in cervical cancer: an update

Expert Review of Anticancer Therapy, 2015
The role of neoadjuvant chemotherapy (NACT) has been investigated in order to improve prognosis of patients with locally advanced cervical cancer. According to a meta-analysis, NACT followed by radiotherapy may be detrimental with a low dose of cisplatin and longer cycle intervals.
LAPRESA, MARIATERESA, Parma, G, Portuesi, R, COLOMBO, NICOLETTA   +3 more
openaire   +3 more sources

Benefits of Neoadjuvant Chemotherapy in NSCLC

Chest, 1996
There is a significant potential benefit for induction chemotherapy in the management of non-small cell lung cancer (NSCLC). The real extent of such benefit is difficult to assess on the basis of available data owing to the intrinsic limitations of phase II studies.
openaire   +2 more sources

Neoadjuvant chemotherapy and ongoing-trials.

Annali italiani di chirurgia, 2011
The history of preoperative therapy for gastric carcinoma was outlined here to demonstrate its value in terms of safety and efficacy.The data collected in this review were obtained from studies found in PubMed using the search terms "preoperative chemotherapy", "preoperative radiotherapy", "preoperative chemoradiotherapy", "neoadjuvant treatment", and
D'Ugo, Domenico, Biondi, Alberto
openaire   +3 more sources

Neoadjuvant Chemotherapy and Biomarkers

2020
Neoadjuvant or presurgical therapy refers to the administration of therapy before surgery and has been used for over two decades to downstage locally advanced and unresectable primary breast cancers to make them operable. The goal of neoadjuvant therapy is to improve surgical outcomes by causing tumor shrinkage by providing effective systemic therapy ...
Niketa Chotai, Supriya Kulkarni
openaire   +1 more source

Neoadjuvant chemotherapy

Nouvelle revue francaise d'hematologie, 1992
M, Weil, D, Khayat
openaire   +4 more sources

Neoadjuvant chemotherapy for cervical cancer

Expert Opinion on Pharmacotherapy, 2003
None of the current surgical or radiation treatment strategies for cervical cancer satisfactorily leads to a high disease-free survival and a low risk for treatment-related complications in patients with bulky or locally-advanced disease. Neoadjuvant chemotherapy (NACT) prior to surgery or radiation therapy has been studied as a means to reduce tumour ...
openaire   +2 more sources

Preoperative (Neoadjuvant) Chemotherapy

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1986
Clinical and Scientific Considerations in Preoperative (Neoadjuvant) Chemotherapy.- Experimental Adjuvant Chemotherapy: An Overview.- Theoretical Considerations Regarding the Early Use of Adjuvant Chemotherapy.- Experimental Preoperative Chemotherapy.- Implications of Certain Cell Kinetic and Biological Parameters for Preoperative Chemotherapy ...
openaire   +3 more sources